Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Phase 2 Recruiting
120 enrolled
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Phase NA Recruiting
1,400 enrolled
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
Recruiting
1,000 enrolled
MINT-2
Phase 2 Recruiting
142 enrolled
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
Phase 1 Recruiting
33 enrolled
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Recruiting
471 enrolled
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
Phase 1 Recruiting
11 enrolled
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
Phase 2 Recruiting
300 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 Recruiting
119 enrolled
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 Recruiting
54 enrolled
RAISE
Phase 2 Recruiting
13 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1/2 Recruiting
40 enrolled
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
Phase 1 Recruiting
22 enrolled
New MRI Biomarkers in Head and Neck Cancers
Recruiting
200 enrolled
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Phase 1 Recruiting
60 enrolled
EMINENCE
Recruiting
390 enrolled
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
Phase 2 Recruiting
120 enrolled
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
Phase 2 Recruiting
53 enrolled
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
Phase NA Recruiting
20 enrolled
Eliminate
Phase 2/3 Recruiting
396 enrolled
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Phase 1 Recruiting
56 enrolled
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 Recruiting
37 enrolled
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
Phase 2 Recruiting
30 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
FIBROTHERME
Phase NA Recruiting
110 enrolled
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Recruiting
1,000 enrolled
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
Phase 2 Recruiting
92 enrolled
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
Phase 1/2 Recruiting
40 enrolled
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Phase 2 Recruiting
30 enrolled
LIGHT
Phase 2 Recruiting
55 enrolled
WOLF
Phase 2 Recruiting
87 enrolled
AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients
Recruiting
20 enrolled
SHERLOCK
Recruiting
7,000 enrolled
Molecular and Genomic Profiling of Head and Neck Tumors
Recruiting
1,000 enrolled
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
Phase 1 Recruiting
6 enrolled
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Phase 2 Recruiting
100 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Parathyroid Tumor Clonal Status
Recruiting
839 enrolled
IDEAL
Phase 2 Recruiting
106 enrolled
HOPE
Phase 3 Recruiting
228 enrolled
GALENOS 2
Phase NA Recruiting
52 enrolled
PRECISE
Phase NA Recruiting
30 enrolled
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 Recruiting
700 enrolled
GALENOS 1
Recruiting
110 enrolled
BIOMATCH
Recruiting
300 enrolled
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Phase 2/3 Recruiting
686 enrolled
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Phase 2 Recruiting
146 enrolled
EURACAN
Recruiting
13,600 enrolled